Lyell Immunopharma (LYEL)
Nasdaq • LYEL • US55083R2031
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 23, 2026, ORTEX estimated 14.4% of free float sold short, 8.7 days to cover, cost to borrow 0.64%. Sign up for live short interest data.
Market Cap
379m USD | # 6438 in US
Volume
169.9k shares | 2m USD
Shares Outstanding
24.59m
Free Float Shares
40.24% | 9.89m
